Program Manages Depression

Published Online: Tuesday, July 1, 2003

Depression is a leading cause of disability in the United States, but it often goes undiagnosed and untreated each year. Research has shown that less than 50% of patients with depression receive adequate treatment, and almost 40% of the patients who start treatment quit shortly after they begin. Patients who are not properly diagnosed and treated for depression can have severe difficulty functioning in everyday life?contributing to an increase in employee absenteeism, a decrease in work productivity, and the inability to function in society.

To combat the rise in depression statistics, PacifiCare Behavioral Health (PBH), based in Santa Ana, Calif, has developed a first-of-its-kind diagnostic system that detects patients with serious depression and manages their care on a long-term basis. Also, PBH has developed a depression management program targeting patients treated for depression within the primary care setting. Recent studies indicate that patients participating in this program significantly improved medication compliance, improved work productivity by 64%, and experienced a 56% reduction in overall symptoms. To learn more about PacifiCare Behavioral Health programs, visit

Latest Articles
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Chronic kidney disease incidence has grown faster than many of its common comorbidities such as diabetes and hypertension, and medications may be an underappreciated driver of this growth.
President Barack Obama’s fiscal year 2017 budget proposal calls for an additional $1.1 billion to combat the nation’s spiraling opioid epidemic.
Baxter International is voluntarily recalling intravenous solution due to leaking containers and the potential for particulate matter.
Latest Issues